Integra Lifesciences Corporation
Clinical trials sponsored by Integra Lifesciences Corporation, explained in plain language.
-
Brain valve registry checks device performance in 160 patients
Disease control OngoingThis study follows 160 patients of any age who have or will receive a CODMAN CERTAS Plus programmable valve to treat hydrocephalus (fluid buildup in the brain). The goal is to see if the valve is placed correctly and works as intended 30 days after surgery. This is an observation…
Sponsor: Integra LifeSciences Corporation • Aim: Disease control
Last updated May 26, 2026 11:28 UTC
-
New wound dressings aim to heal stubborn ulcers faster
Disease control ENROLLING_BY_INVITATIONThis study compares special wound dressings (called CAMPs) plus standard care to standard care alone for healing hard-to-heal diabetic foot and leg ulcers. About 350 adults with these ulcers will be randomly assigned to one of the two groups. The main goal is to see if adding CAM…
Phase: NA • Sponsor: Integra LifeSciences Corporation • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Study on burn scar healing after two graft methods withdrawn
Knowledge-focused TerminatedThis study was designed to observe the quality of burn scars 1 to 3 years after treatment with either Integra or NovoSorb BTM, followed by a skin graft. Researchers planned to review medical records and use non-invasive tools to measure scar quality, along with patient feedback. …
Sponsor: Integra LifeSciences Corporation • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC